Beta

Spending
Congress
Stocks
Lobbying

Spending
Congress
Stocks
Lobbying

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Congress
Stocks
Lobbying

LD-2 disclosure · Registration - Amendment

BARR LABORATORIES

via ZUCKERMAN SPAEDER LLP

4th Quarter (Oct 1 - Dec 31) · 2008Posted Oct 30, 2008Filing document ↗LDA record ↗

Coverage · Registration amendment — updates registrant or client details already on file; not a periodic activity report.

Client

Name: BARR LABORATORIES
Description: Sale of generic pharmaceuticals
Location: District of Columbia · United States of America

Registrant

Firm: ZUCKERMAN SPAEDER LLP
Description: LAW FIRM.
Location: WASHINGTON, District of Columbia, United States of America

Lobbying activities

1 issue

Medical/Disease Research/Clinical Labs
Biogenerics and user fees
LobbyistsLISA BARCLAY

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.

BARR LABORATORIES — Lobbying — Receipts Report